Europe In-Vitro Diagnostics Market will reach US$ 28.88 Billion in 2028, according to Renub Research. In-vitro diagnostics (IVD) refers to medical tests and procedures performed on samples derived from the human body, such as blood, urine, tissue, or other bodily fluids, outside of the body (in vitro) to aid in the diagnosis, monitoring, and prevention of diseases or conditions.

1. Europe In-Vitro Diagnostics
(IVD) Market shall attain US$
28.88 Billion in 2028
Base Year: 2022
Market Research & Advisory

2. 2
2
Europe In-Vitro Diagnostics Market
Renub Research has recently published a report named "Europe In-Vitro Diagnostics (IVD) Market: Global
Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2023-2028," providing a detailed industry
analysis that consists of market share insights. In addition, the report comprises competitor and regional research
and contemporary extension.
Expert Insights: Ask Analyst or Download Full Report with TOC & Figures: https://www.renub.com/europe-
in-vitro-diagnostics-market-p.php
The Europe In-Vitro Diagnostics (IVD) Market shall revel in a CAGR of 2.19% from 2022-2028. In vitro diagnostics
(IVDs) are medical tests completed on organic samples to diagnose and check diseases without the want for
invasive techniques. These assessments offer treasured insights into the body's functioning and typical health,
enabling disorder prognosis, screening, and treatment monitoring. IVDs embody a big selection of technologies,
starting from sophisticated scientific laboratory exams to user-pleasant self-checks like pregnancy and glucose
tracking kits. The European marketplace for in-vitro diagnostics is huge and progressively increasing.
2
https://www.renub.com

3. 3
3
Europe In-Vitro Diagnostics Market
In 2020, the European Union launched tasks with the aim of improving the lives of greater than three million
individuals suffering from cancer by using 2030. These projects are centered on raising consciousness
approximately the significance of early cancer detection. Consequently, there will be an upsurge in the analysis of
chronic illnesses, together with most cancers, in Europe. This increased diagnosis will drive significant growth in the
in-vitro diagnostics market. IVDs also play a crucial role in empowering patients to manage their conditions
effectively. For instance, diabetic individuals can regularly employ portable blood glucose monitors to monitor their
glucose levels. As a result, the growing prevalence of chronic diseases directly impacts the demand for IVD
products.
As per the research study published by Frontiers, over 30% of adults in the European Union (EU) have a
chronic illness or health problem, and the number of individuals with multiple chronic conditions is rising.
Multi-morbidity is particularly prevalent among older adults, with rates reaching up to 65% in those aged
65+ and up to 85% in those aged 85+.
3
https://www.renub.com

4. 4
4
Europe In-Vitro Diagnostics Market
Given the rising demand, the European IVD market is expected to witness robust expansion, supported by the
presence of numerous manufacturers and ongoing research activities across various countries. However, the
complexity and diversity of regulatory frameworks across Europe countries pose challenges in product approvals
and market access, a drawback in the Europe in-vitro diagnostics (IVD) market.
The intricate nature of diagnostic tests drives the prevalence of services in the Europe in-vitro diagnostics
market.
The complexity of diagnostic tests plays a crucial role in driving the widespread adoption of services within the
Europe in-vitro diagnostics market. These tests encompass a wide range of techniques, from advanced laboratory
procedures to user-friendly self-tests, offering valuable insights for disease diagnosis and monitoring. The intricate
nature of these tests ensures the delivery of reliable and precise results, instilling confidence among healthcare
professionals and patients alike. The Europe healthcare system places a strong emphasis on accurate diagnoses
and effective treatment plans, creating a conducive environment for the utilization of advanced diagnostic services.
4
https://www.renub.com

5. 5
5
Europe In-Vitro Diagnostics Market
Rapid technological advancements have led to the development of sophisticated diagnostic tools and techniques,
enabling personalized and targeted treatment strategies. These cutting-edge solutions provide in-depth insights into
various diseases and conditions, allowing for more effective management and improved patient outcomes.
Request a free sample copy of the report: https://www.renub.com/request-sample-page.php?gturl=europe-
in-vitro-diagnostics-market-p.php
Products–Europe in-vitro diagnostics (IVD) Market breakup from 3 Viewpoints:
1. Services 2. Instruments 3. Reagents
Rapid tests will register the highest growth rate in Europe in-vitro diagnostics market.
Rapid tests offer quick results for immediate diagnosis in emergencies and infectious disease outbreaks. They are
convenient, accessible, and suitable for various healthcare settings, enabling early detection, timely interventions,
and improved outcomes. In addition, technological advancements and regulatory support enhance accuracy, ease
of use, and confidence in rapid tests.
5
https://www.renub.com

6. 6
6
Europe In-Vitro Diagnostics Market
Test Types – Europe in-vitro diagnostics (IVD) Market breakup from 11 Viewpoints:
1. ELISA & CLIA 2. PCR
3. Rapid Test 4. Fluorescence Immunoassays (FIA)
5. In Situ Hybridization 6. Transcription Mediated Amplification
7. Sequencing 8. Colorimetric Immunoassay
9. Radioimmunoassay (RIA) 10. Isothermal Nucleic Acid Amplification Technology
11. Others
In Europe in-vitro diagnostics (IVD) market, the primary application is detecting and managing infectious
diseases.
The demand for in-vitro diagnostic tests in Europe is due to the significant burden of infectious diseases, including
the recent COVID-19 pandemic, emphasizing the need for rapid identification and monitoring. Public health
initiatives prioritize disease control, and Europe's robust healthcare infrastructure enables efficient testing and
diagnosis. Advanced technologies, regulatory support, and ongoing research further contribute to Europe's market
dominance in infectious disease diagnostics.
6
https://www.renub.com

7. 7
7
Europe In-Vitro Diagnostics Market
Application – Europe in-vitro diagnostics (IVD) Market breakup from 8 Viewpoints:
1. Infectious Diseases 2. Diabetes 3. Cardiology
4. Oncology 5. Nephrology 6. Autoimmune Diseases
7. Drug Testing 8. Others
Due to their versatility and high sensitivity, immunoassays dominate the Europe in-vitro diagnostic market.
Immunoassays dominate the Europe in-vitro diagnostic market due to their versatility in detecting various analytes,
including proteins, hormones, antibodies, drugs, and infectious agents. They find usage in healthcare settings for
testing infectious diseases, oncology, cardiovascular diseases, autoimmune disorders, and drug testing. With high
sensitivity and specificity, immunoassays provide accurate and reliable results for clinical decision-making and
disease monitoring. Automation advancements ensure scalability and efficiency, especially for high-volume testing.
Strict regulatory guidelines in Europe ensure immunoassay-based diagnostics' quality, safety, and performance. The
availability of reagents, antibodies, and a robust infrastructure of diagnostic laboratories and healthcare facilities
further support their widespread use.
7
https://www.renub.com

8. 8
8
Europe In-Vitro Diagnostics Market
Technology – Europe in-vitro diagnostics (IVD) Market breakup from 7 Viewpoints:
1. Immunoassay 2. Clinical Chemistry 3. Molecular Diagnostics/Genetics
4. Hematology 5. Microbiology 6. Coagulation
7. Others
Technological advancements are propelling the growth of laboratories in the Europe in-vitro diagnostics
(IVD) market.
Europe Healthcare providers outsource diagnostic services to specialized laboratories to meet testing demand and
focus on core competencies. Strict regulatory requirements and quality assurance standards ensure reliable results,
driving laboratory growth. Collaborations with healthcare institutions and research organizations foster innovation
and expand services. Substantial healthcare expenditure in Europe supports laboratory growth and the
development of diagnostic capabilities to meet increasing testing demand.
8
https://www.renub.com

9. 9
9
Europe In-Vitro Diagnostics Market
End-User – Europe in-vitro diagnostics (IVD) Market breakup from 4 Viewpoints:
1. Hospitals 2. Laboratories 3. Home – Care 4. Others
Italy exhibits the highest growth rate among all regions in the Europe in-vitro diagnostics market.
Italy's demand for in-vitro diagnostic tests is due to its robust healthcare infrastructure, substantial disease burden,
and aging population, which contribute to market growth. Government initiatives, investments in healthcare, and
technological advancements are additional factors contributing to market expansion. Collaborations and
partnerships stimulate innovation, while well-established regulatory frameworks ensure the safety and quality of
tests, instilling confidence and promoting growth in the Europe in-vitro diagnostics market.
Regions – Europe in-vitro diagnostics (IVD) Market breakup from 11 Viewpoints:
1. Germany 2. France 3. Italy 4. Spain
5. Netherlands 6. Greece 7. Portugal 8. Austria
9. Belgium 10. Poland 11. Rest of Europe
9
https://www.renub.com

10. 10
10
Europe In-Vitro Diagnostics Market
Competitive Landscape
Prominent Europe in-vitro diagnostics market companies include Roche Diagnostics, Abbott Diagnostics,
Siemens Healthineers, Danaher Corporation, Thermo Fisher Scientific, and Sysmex Corporation.
Company have been covered from 3 Viewpoints:
• Overview • Recent development • Revenue
Company Analysis:
1. Roche Diagnostics 2. Abbott Diagnostics 3. Siemens Healthineers
4. Danaher Corporation 5. Thermo Fisher Scientific 6. Sysmex Corporation
10
https://www.renub.com

11. S
O U T
A U
B
11
https://www.renub.com
Renub Research is a Market Research and Information Analysis company with more than 14 years of experience in
Research, Survey, and Consulting. Our research helps companies to take business decisions: on strategy,
organization, operations, technology, mergers & acquisitions, etc. Till now we have published more than 7000
syndicated reports and worked on more than 500 custom research projects. Currently, we are supplying data to
EMIS, Bloomberg, Thomson Reuters, etc. We support many blue-chip companies by providing them with findings
and perspectives across a wide range of markets.
Media Contact:
Company Name: Renub Research
Contact Person: Rajat Gupta, Marketing Manager
Phone No: +1-478-202-3244 | +91-120-421-9822 (IND)
Address: 225 Kristie Ln, Roswell, GA 30076
Email: info@renub.com
LinkedIn: https://linkedin.com/company/renub-research